for borrower litigation at Bank BPH, see Note 22. Future changes or adverse developments could increase our estimate of total losses and potentially require future cash contributions to Bank BPH.
The Bank BPH financing receivable portfolio is recorded at the lower of cost or fair value, less cost to sell, which reflects market yields and estimates with respect to ongoing borrower litigation. At March 31, 2025, the total portfolio had
no
carrying value, net of a valuation allowance. Income (loss) related to ongoing borrower litigation was
zero
in pre-tax charges for both the three months ended March 31, 2025, and 2024, respectively.
(a) Included $
1,370
million and $
1,324
million of cash, cash equivalents and restricted cash related to Bank BPH as of March 31, 2025 and December 31, 2024, respectively.
(b) Included $
1,553
million and $
1,594
million of valuation allowances against financing receivables held for sale, of which $
1,474
million and $
1,517
million related to estimated borrower litigation losses, and $
976
million and $
944
million in All other liabilities related to estimated borrower litigation losses for Bank BPHâ€™s foreign currency-denominated mortgage portfolio as of March 31, 2025 and December 31, 2024, respectively. Accordingly, total estimated losses related to borrower litigation were $
2,449
million and $
2,461
million as of March 31, 2025 and December 31, 2024, respectively. The valuation allowance completely offsets the financing receivables balance as of March 31, 2025 and December 31, 2024.
NOTE 3.
INVESTMENT SECURITIES.
Current investment securities include
o
ur senior note from AerCap, for which we have adopted the fair value option and matures in the fourth quarter of 2025, with a fair value of $
1,000
million and $
982
million at March 31, 2025 and December 31, 2024, respectively.
Substantially all of our non-current investment securities are held within our run-off insurance operations and are classified as non-current as they support the long-duration insurance liabilities and include debt securities all classified as available-for-sale, substantially all of which are investment-grade.
2025 1Q FORM 10-Q
19
The amortized cost of debt securities excludes accrued interest of $
507
million and $
473
million at March 31, 2025 and December 31, 2024, respectively
, which is reported in All other current assets.
The estimated fair value of investment securities at March 31, 2025 increased since December 31, 2024, primarily due to lower market  yields partially offset by net proceeds from debt/equity securities sales and early redemptions, both from our run-off insurance operations.
Total estimated fair value of debt securities in an unrealized loss position were $
20,859
million and $
21,876
million, of which $
13,913
million and $
14,011
million had gross unrealized losses of $(
2,663
) million and $(
2,795
) million and had been in a loss position for 12 months or more at March 31, 2025 and December 31, 2024,